Changes in HIF-1α, VEGF, NGF and BDNF levels in cerebrospinal fluid and their relationship with cognitive impairment in patients with cerebral infarction

Abstract

This study was carried out to investigate the role of intrinsic neuroprotective mechanisms in the occurrence and development of vascular cognitive impairment (VCI) with the goal of providing a target for the treatment and prevention of VCI. Inpatients with proven cerebral infarction on cranial computed tomography (CT) were recruited as the ischemic cerebrovascular diseases (ICVD) group, and the patients with mixed stroke were excluded. In ICVD group, 12 patients were diagnosed as having VCI and served as VCI group. Inpatients undergoing surgical operation in our hospital were enrolled as control group. Double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) was employed to detect the levels of hypoxia-inducible factor 1-alpha (HIF-1α), vascular endothelial growth factor (VEGF), nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) in the cerebrospinal fluid of patients with ICVD. Associations between the levels of these factors and the Mini-Mental State Examination (MMSE) score were evaluated. In ICVD and VCI groups, the levels of HIF-1α and NGF in the cerebrospinal fluid were markedly lower than those in control group (P=0.037 and P=0.000; P=0.023 and P=0.005). In ICVD and VCI groups, the MMSE score was negatively related to VEGF level in the cerebrospinal fluid (r=−0.327, P=0.021; r=−0.585, P=0.046). In VCI group, HIF-1α level was correlated with NGF level (r=0.589, P=0.044). HIF-1α and NGF are involved in ischemic and hypoxic cerebral injury. The HIF signaling pathway plays an important role in intrinsic neuroprotection. Upregulation and maintenance of HIF-1α and NGF expression may attenuate VCI. Changes in VEGF levels are related to the occurrence and development of cognitive impairment.

Keywords

ischemic cerebrovascular diseases / vascular cognitive impairment / cerebrospinal fluid / hypoxia inducible factor-1α

References

[1] MoorhouseP, RockwoodK. Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurol, 2008, 7(3): 246-255

[2] RuitenbergA, den HeijerT, BakkerSL, et al.. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol, 2005, 57(6): 789-794

[3] SartiC, PantoniL, BartoliniL, et al.. Cognitive impairment and chronic cerebral hypoperfusion: what can be learned from experimental models. J Neurol Sci, 2002, 203–204: 263-266

[4] ScheelP, PulsI, BeckerG, et al.. Volume reduction in cerebral blood flow in patients with vascular dementia. Lancet, 1999, 354(9196): 2137

[5] de la TorreJC. Vascular risk factor detection and control may prevent Alzheimer’s disease. Ageing Res Rev, 2010, 9(3): 218-225

[6] FarkasE, LuitenPG, BariF. Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev, 2007, 54(1): 162-180

[7] de La TorreJC. Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer’s pathogenesis. Neurobiol Aging, 2000, 21(2): 331-342

[8] BergeronM, GiddayJM, YuAY, et al.. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol, 2000, 48(3): 285-296

[9] MartiHJ, BernaudinM, BellailA, et al.. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol, 2000, 156(3): 965-976

[10] KromerLF. Nerve growth factor treatment after brain injury prevents neuronal death. Science, 1987, 235: 214

[11] KodaM, MurakamiM, InoH, et al.. Brain-derived neurotrophic factor suppresses delayed apoptosis of oligodendrocyes after spinal cord injury in rats. Neurotrauma, 2002, 19(6): 777-785

[12] MizunoT, KunoR, NittaA, et al.. Protective effects of nicergoline against neuronai cell death induced by activated mineroglia and astrocytes. Brain Res, 2005, 1066(1–2): 78-85

[13] PloughmanM, WindleV, MaclellanCL, et al.. Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke, 2009, 40(4): 1490-1495

[14] Group of DementiaCognitive Impairment, Branch of Neuropathy of Chinese Medical Association.. Guideline for Diagnosis and Treatment of Vascular Cognitive Impairment. Chin J Neurol (Chinese), 2011, 44(2): 142-147

[15] SemenzaGL. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE, 2007, 2007(407): m8

[16] BenarrochEE. Hypoxia-induced mediators and neurologic disease. Neurology, 2009, 73(7): 560-565

[17] SharpFR, LuA, TangY, et al.. Multiple molecular penumbras after focal cerebral ischemia. J Cereb Blood Flow Metab, 2000, 20(7): 1011-1032

[18] BergeronM, YuAY, SolwayKE, et al.. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci, 1999, 11(12): 4159-4170

[19] MatsudaT, AbeT, WuJL, et al.. Hypoxia-inducible factor-lalpha DNA induced angiogenesis in a rat cerebral ischemia model. Neurol Res, 2005, 27(5): 503-508

[20] LeeTH, KatoH, ChenST, et al.. Expression of nerve growth factor and trkA after transient focal cerebral ischemia in rats. Stroke, 1998, 29(8): 1687-1696

[21] HwangIK, LeeKY, YooKY, et al.. Tyrosine kinase A but not phosphacan/protein tyrosine phosphatase-ζ/β immunoreactivity and protein level changes in neurons and astrocytes in the gerbil hippocampus proper after transient forebrain ischemia. Brain Res, 2005, 1036: 35-41

[22] WienerCM, BoothG, SemenzaGL. In vivo expression of mRNAs encoding hypoxia-inducible factor. Biochem Biophys Res Commun, 1996, 225(2): 485-488

[23] StrokaDM, BurkhardtT, DesbailletsI, et al.. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J, 2001, 15(13): 2445-2453

[24] BaranovaO, MirandaLF, PichiuleP, et al.. Neuron-specific inactivation of the hypoxia inducible factor 1α increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci, 2007, 27(23): 6320-6332

[25] GuoS, BraginaO, XuY, et al.. Glucose up-regulates HIF-1α expression in primary cortical neurons in response to hypoxia through maintaining cellular redox status. J Neurochem, 2008, 105(5): 1849-1860

[26] DemidenkoZN, RapisardaA, GarayoaM, et al.. Accumulation of hypoxia-inducible factor-1α is limited by transcription-dependent depletion. Oncogene, 2005, 24(30): 4829-4838

[27] KongX, Alvarez-CastelaoB, LinZ, et al.. Constitutive/hypoxic degradation of HIF-1α proteins by the proteasome is independent of von Hippel Lindau protein ubiquitylation and the transactivation activity of the protein. J Biol Chem, 2007, 282(21): 15 498-15 505

[28] ShweikiD, ItinA, SofferD, et al.. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature, 1992, 359(6398): 843-845

[29] OgunsholaOO, StewartWB, MihalcikV, et al.. Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain. Brain Res Dev Brain Res, 2000, 119(1): 139-153

[30] KovàcsZ, IkezakiK, SamotoK, et al.. VEGF and flt: expression time kinetics in rat brain infarct. Stroke, 1996, 27(10): 1865-1873

[31] HayashiT, AbeK, SuzukiH, et al.. Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke, 1997, 28(10): 2039-2044

[32] LennmyrF, AtaKA, FunaK, et al.. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. J Neuropathol Exp Neurol, 1998, 57(9): 874-882

[33] KrumJM, ManiN, RosensteinJM. Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Neuroscience, 2002, 110(4): 589-604

[34] HayashiT, AbeK, ItoyamaY. Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J Cereb Blood Flow Metab, 1998, 18(8): 887-895

[35] ZhangZG, ZhangL, JiangQ, et al.. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest, 2000, 106(7): 829-838

[36] BaoWL, LuSD, WangH, et al.. Intraventricular vascular endothelial growth factor antibody increases infarct volume following transient cerebral ischemia. Zhongguo Yao Li Xue Bao, 1999, 20(4): 313-318

[37] TarkowskiaE, IssaR, SjogrenM, et al.. Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer’s disease and vascular dementia. Neurobi Aging, 2000, 23(2): 237-243

[38] LarssonE, KumaR, NorbergA, et al.. Nerve growth factor R221W responsible for insensitivity to pain is defectively processed and accumulates as proNGF. Neurobiol Dis, 2009, 33(2): 221-228

[39] LeeTH, YangJT, KoYS, et al.. Influence of ischemic preconditioning on levels of nerve growth factor, brain-derived neurotrophic factor and their high-affinity receptors in hippocampus following forebrain ischemia. Brain Res, 2008, 1187: 1-11

[40] WaltonM, ConnorB, LawlorP. Neuronal death and survival in two models of hypoxic-ischemic brain damage. Brain Res Brain Res Rev, 1999, 29(23): 137-168

[41] SchabitzWR, SchwabS, SprangerM, et al.. Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemic in rats. J Cereb Blood Flow Metab, 1997, 17(5): 500-506

[42] ZhouH, MaoM, LiuWP, et al.. Expression of BDNF receptor TrkBmRNA in hypoxia-induced fetal cortical neurons. Huaxi Yike Daxue Xuebao (Chinese), 2002, 33(4): 573-576

[43] NakamuraK, MartinKC, JacksonJK, et al.. Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells. Cancer Res, 2006, 66(8): 4249-4255

[44] NakamuraK, TanF, LiZJ, et al.. NGF activation of TrkA induces vascular endothelial growth factor expression via induction of hypoxia-inducible factor-1α. Mol Cell Neurosci, 2011, 46(2): 498-506